CoChat

The effects of PEGylation on LNP based mRNA delivery to the eye

Open access

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Abstract

Gene therapy is now an effective approach to treat many forms of retinal degeneration. Delivery agents that are cell-specific, allow for multiple dosing regimens, and have low immunogenicity are needed to expand the utility of gene therapy for the retina. We generated eight novel lipid nanoparticles (LNPs) ranging in size from 50 nm to 150 nm by changing the PEG content from 5% to 0.5%, respectively. Subretinal injections of LNP-mRNA encoding luciferase revealed that 0.5% PEG content within nanoparticles elicits the highest expression. Similar injections of LNP delivered cre mRNA into Ai9 mice revealed cell-specific protein expression in the retinal pigment epithelium (RPE), confirmed by fundus photography and immunohistochemistry of whole globe cross-sections. To investigate mechanisms of LNP delivery to the eye, we injected mCherry mRNA using the subretinal approach in apoE-/- and Mertk-/- mice. RPE transfection was observed in both mouse models suggesting that LNP intracellular delivery is not solely dependent on apolipoprotein adsorption or phagocytosis. To investigate LNP penetration, particles were delivered to the vitreous chamber via an intravitreal injection. The 0.5% PEG particles mediated the highest luciferase activity and expression was observed in the Müller glia, the optic nerve head and the trabecular meshwork, but failed to reach the RPE. Overall, particles containing less PEG (~150 nm in size) mediated the highest expression in the eye. Thus far, these particles successfully transfect RPE, Müller cells, the optic nerve head and the trabecular meshwork based on route of administration which can expand the utility of LNP-mediated gene therapies for the eye.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0241006

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 LNP characterization. (A) Schematic of an LNP listing all major components. (B) Bar graph showing the size and PDI of one set of particles when percentage of PEG is increased and modulated against cholesterol. (C) Bar graph showing size and PDI of one set of particles when percentage of PEG is increased and modulated against DSPC. DSPC-1,2-distearoyl-sn-glycero-3-phosphocholine, DMG-PEG2k-1,2-dimyristoyl-rac-glycero-3-methoxypolyethylene glycol-2000, MC3-Dlin-MC3-DMA, PDI-polydispersity index.
Fig 1 LNP characterization. (A) Schematic of an LNP listing all major components. (B) Bar graph showing the size and PDI of one set of particles when percentage of PEG is increased and modulated against cholesterol. (C) Bar graph showing size and PDI of one set of particles when percentage of PEG is increased and modulated against DSPC. DSPC-1,2-distearoyl-sn-glycero-3-phosphocholine, DMG-PEG2k-1,2-dimyristoyl-rac-glycero-3-methoxypolyethylene glycol-2000, MC3-Dlin-MC3-DMA, PDI-polydispersity index.CC BY · PubMed Central
Fig 2 The effects of LNP size and cholesterol modifications post-subretinal injection. (A) Representative images demonstrating luciferase activity in the eye 24 hours post-injection. (B) Luciferase activity plotted for each group over time. Data are presented as mean ± SD. A two-way ANOVA, Tukey’s multiple comparisons test was used for analysis. *p<0.05. n = 3–6. (C) Representative bright field (top) and tdTomato (bottom) fundus images for each group taken 7 days post-injection. (D) Quantification of tdTomato intensity, represented as a fold change compared to PBS. Data are presented as mean ± SD. An ordinary one-way ANOVA, with Tukey’s correction for multiple comparisons test was used for comparisons. *p<0.05. n = 3–6. (E) Representative confocal images of immunohistochemistry showing RFP expression in the RPE for all groups. n.s.—not significant, LNP- lipid nanoparticle, RFP-red fluorescent protein, RPE-retinal pigment epithelium, ONL- outer nuclear layer, INL-inner nuclear layer, GCL- ganglion cell layer.
Fig 2 The effects of LNP size and cholesterol modifications post-subretinal injection. (A) Representative images demonstrating luciferase activity in the eye 24 hours post-injection. (B) Luciferase activity plotted for each group over time. Data are presented as mean ± SD. A two-way ANOVA, Tukey’s multiple comparisons test was used for analysis. *p<0.05. n = 3–6. (C) Representative bright field (top) and tdTomato (bottom) fundus images for each group taken 7 days post-injection. (D) Quantification of tdTomato intensity, represented as a fold change compared to PBS. Data are presented as mean ± SD. An ordinary one-way ANOVA, with Tukey’s correction for multiple comparisons test was used for comparisons. *p<0.05. n = 3–6. (E) Representative confocal images of immunohistochemistry showing RFP expression in the RPE for all groups. n.s.—not significant, LNP- lipid nanoparticle, RFP-red fluorescent protein, RPE-retinal pigment epithelium, ONL- outer nuclear layer, INL-inner nuclear layer, GCL- ganglion cell layer.CC BY · PubMed Central
Fig 3 The effects of LNP size and DSPC modifications post-subretinal injection. (A) Representative images demonstrating luciferase activity in the eye 24 hours post-injection. (B) Luciferase activity plotted for each group over time. Data are presented as mean ± SD. A two-way ANOVA, Tukey’s multiple comparisons test was used for analysis. *p<0.05. n = 3–6. (C) Representative bright field (top) and tdTomato (bottom) fundus images for each group taken 7 days post-injection. (D) Quantification of tdTomato intensity, represented as a fold change compared to PBS. Data are presented as mean ± SD. An ordinary one-way ANOVA, with Tukey’s correction for multiple comparisons test was used for comparisons. n = 3–6. (E) Representative confocal images of immunohistochemistry showing RFP expression in the RPE for all groups. n.s.—not significant, LNP- lipid nanoparticle, RFP-red fluorescent protein, RPE-retinal pigment epithelium, ONL- outer nuclear layer, INL-inner nuclear layer, GCL- ganglion cell layer.
Fig 3 The effects of LNP size and DSPC modifications post-subretinal injection. (A) Representative images demonstrating luciferase activity in the eye 24 hours post-injection. (B) Luciferase activity plotted for each group over time. Data are presented as mean ± SD. A two-way ANOVA, Tukey’s multiple comparisons test was used for analysis. *p<0.05. n = 3–6. (C) Representative bright field (top) and tdTomato (bottom) fundus images for each group taken 7 days post-injection. (D) Quantification of tdTomato intensity, represented as a fold change compared to PBS. Data are presented as mean ± SD. An ordinary one-way ANOVA, with Tukey’s correction for multiple comparisons test was used for comparisons. n = 3–6. (E) Representative confocal images of immunohistochemistry showing RFP expression in the RPE for all groups. n.s.—not significant, LNP- lipid nanoparticle, RFP-red fluorescent protein, RPE-retinal pigment epithelium, ONL- outer nuclear layer, INL-inner nuclear layer, GCL- ganglion cell layer.CC BY · PubMed Central
Fig 4 LNP-mediated RPE expression is not dependent on apoE or the MERTK receptor. (A) Representative images demonstrating luciferase activity in C57BL6 and apoE-/- eyes 24 hours post-injection. (B) Luciferase activity plotted for both groups at 24 hours post-injection. Data are presented as mean ± SD. An unpaired t-test was used for analysis. n = 4. (C) Representative confocal images of immunohistochemistry showing mCherry expression in the RPE of C57BL6, apoE-/- and Mertk-/- mice. n.s.—not significant, PBS-phosphate buffered saline, LNP- lipid nanoparticle, RPE-retinal pigment epithelium, ONL- outer nuclear layer, INL-inner nuclear layer, GCL- ganglion cell layer.
Fig 4 LNP-mediated RPE expression is not dependent on apoE or the MERTK receptor. (A) Representative images demonstrating luciferase activity in C57BL6 and apoE-/- eyes 24 hours post-injection. (B) Luciferase activity plotted for both groups at 24 hours post-injection. Data are presented as mean ± SD. An unpaired t-test was used for analysis. n = 4. (C) Representative confocal images of immunohistochemistry showing mCherry expression in the RPE of C57BL6, apoE-/- and Mertk-/- mice. n.s.—not significant, PBS-phosphate buffered saline, LNP- lipid nanoparticle, RPE-retinal pigment epithelium, ONL- outer nuclear layer, INL-inner nuclear layer, GCL- ganglion cell layer.CC BY · PubMed Central
Fig 5 The effects of LNP size and cholesterol modifications post-intravitreal injection. (A) Representative images demonstrating luciferase activity in the eye 24 hours post-injection. (B) Luciferase activity plotted for each group over time. Data are presented as mean ± SD. A two-way ANOVA, Tukey’s multiple comparisons test was used for analysis. *p<0.05. n = 3–6. (C) Representative bright field (top) and tdTomato (bottom) fundus images for each group taken 7 days post-injection. (D) Quantification of tdTomato intensity, represented as a fold change compared to PBS. Data are presented as mean ± SD. An ordinary one-way ANOVA, with Tukey’s correction for multiple comparisons test was used for comparisons. n = 3–6. (E) Representative confocal images of immunohistochemistry showing RFP expression in the Müller glia, the ONH and the TM for all groups. n.s.—not significant, LNP- lipid nanoparticle, RFP-red fluorescent protein, ONL- outer nuclear layer, INL-inner nuclear layer, GCL- ganglion cell layer, ONH-optic nerve head, TM-trabecular meshwork, CB-ciliary body.
Fig 5 The effects of LNP size and cholesterol modifications post-intravitreal injection. (A) Representative images demonstrating luciferase activity in the eye 24 hours post-injection. (B) Luciferase activity plotted for each group over time. Data are presented as mean ± SD. A two-way ANOVA, Tukey’s multiple comparisons test was used for analysis. *p<0.05. n = 3–6. (C) Representative bright field (top) and tdTomato (bottom) fundus images for each group taken 7 days post-injection. (D) Quantification of tdTomato intensity, represented as a fold change compared to PBS. Data are presented as mean ± SD. An ordinary one-way ANOVA, with Tukey’s correction for multiple comparisons test was used for comparisons. n = 3–6. (E) Representative confocal images of immunohistochemistry showing RFP expression in the Müller glia, the ONH and the TM for all groups. n.s.—not significant, LNP- lipid nanoparticle, RFP-red fluorescent protein, ONL- outer nuclear layer, INL-inner nuclear layer, GCL- ganglion cell layer, ONH-optic nerve head, TM-trabecular meshwork, CB-ciliary body.CC BY · PubMed Central
Fig 6 The effects of LNP size and DSPC modifications post-intravitreal injection. (A) Representative images demonstrating luciferase activity in the eye 24 hours post-injection. (B) Luciferase activity plotted for each group over time. Data are presented as mean ± SD. A two-way ANOVA, Tukey’s multiple comparisons test was used for analysis. *p<0.05. n = 3–6. (C) Representative bright field (top) and tdTomato (bottom) fundus images for each group taken 7 days post-injection. (D) Quantification of tdTomato intensity, represented as a fold change compared to PBS. Data are presented as mean ± SD. An ordinary one-way ANOVA, with Tukey’s correction for multiple comparisons test was used for comparisons. *p<0.05. n = 3–6. (E) Representative confocal images of immunohistochemistry showing RFP expression in the Müller glia, the ONH and the TM. n.s.—not significant, LNP- lipid nanoparticle, RFP-red fluorescent protein, ONL- outer nuclear layer, INL-inner nuclear layer, GCL- ganglion cell layer, ONH-optic nerve head, TM-trabecular meshwork, CB-ciliary body.
Fig 6 The effects of LNP size and DSPC modifications post-intravitreal injection. (A) Representative images demonstrating luciferase activity in the eye 24 hours post-injection. (B) Luciferase activity plotted for each group over time. Data are presented as mean ± SD. A two-way ANOVA, Tukey’s multiple comparisons test was used for analysis. *p<0.05. n = 3–6. (C) Representative bright field (top) and tdTomato (bottom) fundus images for each group taken 7 days post-injection. (D) Quantification of tdTomato intensity, represented as a fold change compared to PBS. Data are presented as mean ± SD. An ordinary one-way ANOVA, with Tukey’s correction for multiple comparisons test was used for comparisons. *p<0.05. n = 3–6. (E) Representative confocal images of immunohistochemistry showing RFP expression in the Müller glia, the ONH and the TM. n.s.—not significant, LNP- lipid nanoparticle, RFP-red fluorescent protein, ONL- outer nuclear layer, INL-inner nuclear layer, GCL- ganglion cell layer, ONH-optic nerve head, TM-trabecular meshwork, CB-ciliary body.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Research works printed but not linked: 2

  1. C Kay, 2019, Retinal Gene Therapies in Clinical Trials A proliferation of clinical trials means hope for patients, Retinal Physician, 16, 36
  2. T Borrás, 2017, The Pathway From Genes to Gene Therapy in Glaucoma: A Review of Possibilities for Using Genes as Glaucoma Drugs., Asia Pac J Ophthalmol (Phila)., 6, 80

Cited by

See all 194

Metadata

Authors
Ryals, R. C., Patel, S., Acosta, C., McKinney, M., Pennesi, M. E., & Sahay, G.
Affiliations
  • Oregon Health & Science University (US)
  • Oregon State University (US)
Corresponding author
Sahay, Gaurav
Venue
PLOS ONE
Published
2020-10-29
Volume
15
Issue
10
Pages
e0241006
ISSN
1932-6203 (ISSN-L)
OpenAlex
W3096490487
Cited by
194
References
40
Citations by year
2026: 30 · 2025: 42 · 2024: 32 · 2023: 37 · 2022: 35 · 2021: 17 · 2020: 1
FWCI
7.30
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institutes of Health (P30 EY010572)
  • National Eye Institute (1R21EY031066-01A1)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
Keywords
PEGylation, lipid nanoparticles, mRNA delivery, ocular gene therapy, retinal degeneration, subretinal injection, intravitreal injection, retinal pigment epithelium, apolipoprotein E, MERTK, Müller cells, optic nerve head, trabecular meshwork, particle size
MeSH terms
Mice, Knockout, ApoE, Red Fluorescent Protein, Animals, Female, Fundus Oculi, Lipids, Luminescent Proteins, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Particle Size, Polyethylene Glycols, RNA, Messenger, Drug Delivery Systems, Gene Transfer Techniques, Nanoparticles, Retinal Pigment Epithelium, Intravitreal Injections

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The effects of PEGylation on LNP based mRNA delivery to the eye. https://app.cochat.ai/papers/10.1371/journal.pone.0241006
The paper
Ryals, R. C., Patel, S., Acosta, C., McKinney, M., Pennesi, M. E., & Sahay, G. (2020). The effects of PEGylation on LNP based mRNA delivery to the eye. PLOS ONE. https://doi.org/10.1371/journal.pone.0241006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.